307 related articles for article (PubMed ID: 25274034)
1. Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling.
Pinto MP; Dye WW; Jacobsen BM; Horwitz KB
BMC Cancer; 2014 Oct; 14():735. PubMed ID: 25274034
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer.
Pinto MP; Badtke MM; Dudevoir ML; Harrell JC; Jacobsen BM; Horwitz KB
Cancer Res; 2010 Apr; 70(7):2655-64. PubMed ID: 20332242
[TBL] [Abstract][Full Text] [Related]
3. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
Pietras K; Pahler J; Bergers G; Hanahan D
PLoS Med; 2008 Jan; 5(1):e19. PubMed ID: 18232728
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes.
Kadivar A; Kamalidehghan B; Akbari Javar H; Karimi B; Sedghi R; Noordin MI
Drug Des Devel Ther; 2017; 11():469-481. PubMed ID: 28260860
[TBL] [Abstract][Full Text] [Related]
5. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
Kinoshita K; Nakagawa K; Hamada J; Hida Y; Tada M; Kondo S; Moriuchi T
Int J Oncol; 2010 Oct; 37(4):869-77. PubMed ID: 20811709
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice.
Shan H; Takahashi T; Bando Y; Izumi K; Uehara H
Cancer Sci; 2011 Oct; 102(10):1904-10. PubMed ID: 21733044
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic endothelial cells support tumor growth in breast cancer.
Lee E; Pandey NB; Popel AS
Sci Rep; 2014 Jul; 4():5853. PubMed ID: 25068296
[TBL] [Abstract][Full Text] [Related]
8. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer.
Bos R; van Diest PJ; de Jong JS; van der Groep P; van der Valk P; van der Wall E
Histopathology; 2005 Jan; 46(1):31-6. PubMed ID: 15656883
[TBL] [Abstract][Full Text] [Related]
11. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors.
Battegay EJ; Rupp J; Iruela-Arispe L; Sage EH; Pech M
J Cell Biol; 1994 May; 125(4):917-28. PubMed ID: 7514607
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.
Eiro N; González L; Martínez-Ordoñez A; Fernandez-Garcia B; González LO; Cid S; Dominguez F; Perez-Fernandez R; Vizoso FJ
Cell Oncol (Dordr); 2018 Aug; 41(4):369-378. PubMed ID: 29497991
[TBL] [Abstract][Full Text] [Related]
13. Specific targeting of PDGFRβ in the stroma inhibits growth and angiogenesis in tumors with high PDGF-BB expression.
Tsioumpekou M; Cunha SI; Ma H; Åhgren A; Cedervall J; Olsson AK; Heldin CH; Lennartsson J
Theranostics; 2020; 10(3):1122-1135. PubMed ID: 31938055
[TBL] [Abstract][Full Text] [Related]
14. Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion.
Benyahia Z; Dussault N; Cayol M; Sigaud R; Berenguer-Daizé C; Delfino C; Tounsi A; Garcia S; Martin PM; Mabrouk K; Ouafik L
Oncotarget; 2017 Feb; 8(9):15744-15762. PubMed ID: 28178651
[TBL] [Abstract][Full Text] [Related]
15. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
16. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527
[TBL] [Abstract][Full Text] [Related]
17. Interface between breast cancer cells and the tumor microenvironment using platelet-rich plasma to promote tumor angiogenesis - influence of platelets and fibrin bundles on the behavior of breast tumor cells.
Andrade SS; Sumikawa JT; Castro ED; Batista FP; Paredes-Gamero E; Oliveira LC; Guerra IM; Peres GB; Cavalheiro RP; Juliano L; Nazário AP; Facina G; Tsai SM; Oliva ML; Girão MJ
Oncotarget; 2017 Mar; 8(10):16851-16874. PubMed ID: 28187434
[TBL] [Abstract][Full Text] [Related]
18. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
19. Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors.
Lebret SC; Newgreen DF; Thompson EW; Ackland ML
Breast Cancer Res; 2007; 9(1):R19. PubMed ID: 17311675
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
Lederle W; Stark HJ; Skobe M; Fusenig NE; Mueller MM
Am J Pathol; 2006 Nov; 169(5):1767-83. PubMed ID: 17071599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
